295 related articles for article (PubMed ID: 12759346)
1. Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation.
Fu X; Kassim SY; Parks WC; Heinecke JW
J Biol Chem; 2003 Aug; 278(31):28403-9. PubMed ID: 12759346
[TBL] [Abstract][Full Text] [Related]
2. Oxidative cross-linking of tryptophan to glycine restrains matrix metalloproteinase activity: specific structural motifs control protein oxidation.
Fu X; Kao JL; Bergt C; Kassim SY; Huq NP; d'Avignon A; Parks WC; Mecham RP; Heinecke JW
J Biol Chem; 2004 Feb; 279(8):6209-12. PubMed ID: 14670964
[TBL] [Abstract][Full Text] [Related]
3. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase.
Fu X; Kassim SY; Parks WC; Heinecke JW
J Biol Chem; 2001 Nov; 276(44):41279-87. PubMed ID: 11533038
[TBL] [Abstract][Full Text] [Related]
4. Methionine sulfoxide and proteolytic cleavage contribute to the inactivation of cathepsin G by hypochlorous acid: an oxidative mechanism for regulation of serine proteinases by myeloperoxidase.
Shao B; Belaaouaj A; Verlinde CL; Fu X; Heinecke JW
J Biol Chem; 2005 Aug; 280(32):29311-21. PubMed ID: 15967795
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation.
Wang Y; Rosen H; Madtes DK; Shao B; Martin TR; Heinecke JW; Fu X
J Biol Chem; 2007 Nov; 282(44):31826-34. PubMed ID: 17726014
[TBL] [Abstract][Full Text] [Related]
6. Specific sequence motifs direct the oxygenation and chlorination of tryptophan by myeloperoxidase.
Fu X; Wang Y; Kao J; Irwin A; d'Avignon A; Mecham RP; Parks WC; Heinecke JW
Biochemistry; 2006 Mar; 45(12):3961-71. PubMed ID: 16548523
[TBL] [Abstract][Full Text] [Related]
7. Hypochlorous acid generated by neutrophils inactivates ADAMTS13: an oxidative mechanism for regulating ADAMTS13 proteolytic activity during inflammation.
Wang Y; Chen J; Ling M; López JA; Chung DW; Fu X
J Biol Chem; 2015 Jan; 290(3):1422-31. PubMed ID: 25422322
[TBL] [Abstract][Full Text] [Related]
8. Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro.
Yang CY; Gu ZW; Yang M; Lin SN; Garcia-Prats AJ; Rogers LK; Welty SE; Smith CV
J Lipid Res; 1999 Apr; 40(4):686-98. PubMed ID: 10191293
[TBL] [Abstract][Full Text] [Related]
9. Generation of intramolecular and intermolecular sulfenamides, sulfinamides, and sulfonamides by hypochlorous acid: a potential pathway for oxidative cross-linking of low-density lipoprotein by myeloperoxidase.
Fu X; Mueller DM; Heinecke JW
Biochemistry; 2002 Jan; 41(4):1293-301. PubMed ID: 11802729
[TBL] [Abstract][Full Text] [Related]
10. Potential role of methionine sulfoxide in the inactivation of the chaperone GroEL by hypochlorous acid (HOCl) and peroxynitrite (ONOO-).
Khor HK; Fisher MT; Schöneich C
J Biol Chem; 2004 May; 279(19):19486-93. PubMed ID: 14757771
[TBL] [Abstract][Full Text] [Related]
11. Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein.
Bergt C; Fu X; Huq NP; Kao J; Heinecke JW
J Biol Chem; 2004 Feb; 279(9):7856-66. PubMed ID: 14660678
[TBL] [Abstract][Full Text] [Related]
12. Modification of tryptophan and methionine residues is implicated in the oxidative inactivation of surfactant protein B.
Manzanares D; Rodriguez-Capote K; Liu S; Haines T; Ramos Y; Zhao L; Doherty-Kirby A; Lajoie G; Possmayer F
Biochemistry; 2007 May; 46(18):5604-15. PubMed ID: 17425286
[TBL] [Abstract][Full Text] [Related]
13. Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13.
Chen J; Fu X; Wang Y; Ling M; McMullen B; Kulman J; Chung DW; López JA
Blood; 2010 Jan; 115(3):706-12. PubMed ID: 19812385
[TBL] [Abstract][Full Text] [Related]
14. Novel intra- and inter-molecular sulfinamide bonds in S100A8 produced by hypochlorite oxidation.
Raftery MJ; Yang Z; Valenzuela SM; Geczy CL
J Biol Chem; 2001 Sep; 276(36):33393-401. PubMed ID: 11445563
[TBL] [Abstract][Full Text] [Related]
15. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation.
Anderson MM; Hazen SL; Hsu FF; Heinecke JW
J Clin Invest; 1997 Feb; 99(3):424-32. PubMed ID: 9022075
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of neutrophil glutathione and protein thiols by myeloperoxidase-derived hypochlorous acid.
Carr AC; Winterbourn CC
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):275-81. PubMed ID: 9355763
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes.
Heinecke JW; Li W; Mueller DM; Bohrer A; Turk J
Biochemistry; 1994 Aug; 33(33):10127-36. PubMed ID: 8060981
[TBL] [Abstract][Full Text] [Related]
18. Comparison of HOCl traps with myeloperoxidase inhibitors in prevention of low density lipoprotein oxidation.
Jerlich A; Fritz G; Kharrazi H; Hammel M; Tschabuschnig S; Glatter O; Schaur RJ
Biochim Biophys Acta; 2000 Aug; 1481(1):109-18. PubMed ID: 11004581
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of oxidizing agents on human plasma alpha 1-proteinase inhibitor and human neutrophil myeloperoxidase.
Matheson NR; Travis J
Biochemistry; 1985 Apr; 24(8):1941-5. PubMed ID: 2990544
[TBL] [Abstract][Full Text] [Related]
20. Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils.
Rosen H; Klebanoff SJ; Wang Y; Brot N; Heinecke JW; Fu X
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18686-91. PubMed ID: 19833874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
